NOTE: On July 1, 2020, PolyOne and Clariant Masterbatch joined together as Avient, a new  kind of materials company focused on conquering customer challenges and unlocking the potential for innovation and sustainability around the globe.

NOTE: On July 1, 2020, PolyOne and Clariant Masterbatches joined together as Avient, a new kind of materials company focused on conquering customer challenges and unlocking the potential for innovation and sustainability around the globe.

NOTE: On July 1, 2020, PolyOne and Clariant Masterbatches joined together as Avient, a new kind of materials company focused on conquering customer challenges and unlocking the potential for innovation and sustainability around the globe.

NOTE: On July 1, 2020, PolyOne and Clariant Masterbatches joined together as Avient, a new kind of materials company focused on conquering customer challenges and unlocking the potential for innovation and sustainability around the globe.

Avient has transitioned our Material Safety Data Sheets (MSDSs) to Safety Data Sheets (SDSs) for our manufactured products to meet the requirements of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), and CLP classification in Europe. Technical Data Sheets Safety Data Sheets

Avient has transitioned our Material Safety Data Sheets (MSDSs) to Safety Data Sheets (SDSs) for our manufactured products to meet the requirements of the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), and CLP classification in Europe. Technical Data Sheets Safety Data Sheets

Strong past performance demonstrates that our strategy and execution are working • Megatrends align with our strengths • Innovation and services provide differentiation and competitive advantage • Strong and proven management team driving growth and performance • Addressable market exceeds $40 billion The New PolyOne: A Specialty Growth Company 2015 Target: $2.50 Adjusted EPS Page 15 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S. Average Debt Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average PolyOne Debt $ 705.8 $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 840.9 Average Equity Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average PolyOne shareholders’ equity $ 604.3 $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 745.7 Platform sales and operating income (OI) H1 2012*** H1 2013*** H1 2013**** Global Specialty Engineered Materials Sales $ 280.9 $ 352.0 $ 285.1 Global Color, Additives and Inks Sales 413.9 434.7 409.2 Designed Structures & Solutions Sales - 240.4 - Specialty Platform Sales $ 694.8 $ 1,027.1 $694.3 Performance Products and Solutions Sales 336.0 336.7 317.5 PolyOne Distribution Sales 533.6 543.1 543.1 Corporate and Eliminations (62.3) (68.2) (68.2) Total Sales $ 1,502.1 $ 1,838.7 $ 1,486.7 Global Specialty Engineered Materials OI $ 24.6 $ 32.5 $ 31.2 Global Color, Additives and Inks OI 44.0 54.7 52.0 Designed Structures & Solutions OI - 10.5 - Specialty Platform OI $ 68.6 $ 97.7 $ 83.2 Performance Products and Solutions OI 19.3 27.5 25.7 PolyOne Distribution OI 33.4 33.1 33.1 Corporate and eliminations (20.3) (25.7) (20.3) Special items in OI (20.3) (11.4) (20.3) Operating income - GAAP $ 80.7 $ 121.2 $ 101.4 Special items in OI 20.3 11.4 20.3 Operating income adjusted $ 101.0 $ 132.6 $ 121.7 Global Specialty Engineered Materials - OI % of sales 8.8% 9.2% 10.9% Global Color, Additives and Inks - OI % of sales 10.6% 12.6% 12.7% Designed Structures & Solutions - OI % of sales - 4.4% - Specialty platform - OI % of sales 9.9% 9.5% 12.0% PP&S operating - OI % of sales 5.7% 8.2% 8.1% Distribution OI - % of sales 6.3% 6.1% 6.1% PolyOne OI adjusted - % of sales 6.7% 7.2% 8.2% Reconciliation to Condensed Consolidated Balance Sheets H1 2013 Short-term debt and current portion of long-term debt $ 8.7 Long-term debt 1,022.5 Less cash and cash equivalents (392.4) Specialty Platform Gross Margin Percentage 2006Y* Q2 2013**** Global Specialty Engineered Materials Sales $ 345.3 $ 143.5 Global Color, Additives and Inks Sales 531.8 207.5 Specialty Platform Sales $ 877.1 $ 351.0 Global Specialty Engineered Materials Gross Margin $ 41.6 $ 37.3 Global Color, Additives and Inks Gross Margin 83.6 71.8 Specialty Platform Gross Margin $ 125.2 $ 109.1 Specialty Platform Gross Margin Percentage 14.3% 31.1% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment. Credit Suisse September 2013 Investor Presentation non-GAAP v2.pdf Reconciliation to Condensed Consolidated Balance Sheets

Strong past performance demonstrates that our strategy and execution are working • Megatrends align with our strengths • Innovation and services provide differentiation and competitive advantage • Strong and proven management team driving growth and performance • Addressable market exceeds $40 billion The New PolyOne: A Specialty Growth Company 2015 Target: $2.50 Adjusted EPS Page 15 Schedule I Reconciliation of Non-GAAP Financial Measures (Unaudited) (Dollars in millions, except per share data) Below is a reconciliation of non-GAAP financial measures to the most directly comparable measures calculated and presented in accordance with U.S. Average Debt Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average PolyOne Debt $ 705.8 $ 705.2 $ 706.9 $ 1,055.5 $ 1,031.2 $ 840.9 Average Equity Q2 2012 Q3 2012 Q4 2012 Q1 2013 Q2 2013 Average PolyOne shareholders’ equity $ 604.3 $ 629.3 $ 629.1 $ 871.8 $ 993.9 $ 745.7 Platform sales and operating income (OI) H1 2012*** H1 2013*** Global Specialty Engineered Materials Sales $ 280.9 $ 352.0 Global Color, Additives and Inks Sales 413.9 434.7 Designed Structures & Solutions Sales - 240.4 Specialty Platform Sales 694.8 1,027.1 Performance Products and Solutions Sales 336.0 336.7 PolyOne Distribution Sales 533.6 543.1 Corporate and Eliminations (62.3) (68.2) Total Sales $ 1,502.1 $ 1,838.7 Global Specialty Engineered Materials OI $ 24.6 $ 32.5 Global Color, Additives and Inks OI 44.0 54.7 Designed Structures & Solutions OI - 10.5 Specialty Platform OI $ 68.6 $ 97.7 Performance Products and Solutions OI 19.3 27.5 PolyOne Distribution OI 33.4 33.1 Corporate and eliminations (20.3) (25.7) Special items in OI (20.3) (11.4) Operating income - GAAP $ 80.7 $ 121.2 Special items in OI 20.3 11.4 Operating income adjusted $ 101.0 $ 132.6 Global Specialty Engineered Materials - OI % of sales 8.8% 9.2% Global Color, Additives and Inks - OI % of sales 10.6% 12.6% Designed Structures & Solutions – OI % of sales - 4.4% Specialty platform OI % of sales 9.9% 9.5% PP&S operating OI % of sales 5.7% 8.2% Distribution OI % of sales 6.3% 6.1% PolyOne OI adjusted, % of sales 6.7% 7.2% Reconciliation to Condensed Consolidated Balance Sheets H1 2013 Short-term debt and current portion of long-term debt $ 8.7 Long-term debt 1,022.5 Less cash and cash equivalents (392.4) Specialty Platform Gross Margin Percentage 2006Y* Q2 2013**** Global Specialty Engineered Materials Sales $ 345.3 $ 143.5 Global Color, Additives and Inks Sales 531.8 207.5 Specialty Platform Sales $ 877.1 $ 351.0 Global Specialty Engineered Materials Gross Margin $ 41.6 37.3 Global Color, Additives and Inks Gross Margin 83.6 71.8 Specialty Platform Gross Margin $ 125.2 $ 109.1 Specialty Platform Gross Margin Percentage 14.3% 31.1% * Historical results include the Resin and Specialty Coatings businesses within the Performance Products and Solutions segment. August 13 - Jefferies 2013 Investor Presentation non-GAAP v2 (2).pdf Reconciliation to Condensed Consolidated Balance Sheets

We then paid down $950 million of debt, providing us a strong balance sheet to navigate through this period of macro-economic uncertainty.” 3 “We have never wavered from our goal of becoming a specialty formulator. This includes restructuring actions to accelerate the remaining synergies associated with the Clariant Color acquisition, particularly in Europe.” Rose Vice President, Corporate Communications Avient Corporation +1 440-930-3162 kyle.rose@avient.com 8 Attachment 1 Avient Corporation Summary of Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 2021 Sales $ 790.4 $ 807.1 $ 3,396.9 $ 3,315.5 Operating Income 0.4 50.2 243.3 279.7 Net (loss) income from continuing operations attributable to Avient shareholders (17.0) 11.2 82.8 151.8 Diluted (loss) earnings per share from continuing operations attributable to Avient shareholders $ (0.19) $ 0.12 $ 0.90 $ 1.65 Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results.

Additionally, Avient’s ISO 13485 manufacturing site in Singapore for its Mevopur™ formulations recently achieved ISO/IEC 17025 accreditation for Biological Evaluation of Medical Devices–Part 5: Tests for In-Vitro Cytotoxicity.  Mevopur™ Healthcare Colorants and Functional Additives: formulations pre-tested to support compliance with regulatory requirements, such as USP Class VI, ISO 10993, EP3.1, USP661.1, and ICH Q3D and manufactured across a global network of ISO 13485-certified facilities or under GMP certifications. TPEs and specialty engineered polymers for auto-injector pens: offer excellent chemical and impact resistance, good self-lubrication functions, durability to extend product life and meet biocompatibility and food-contact safety regulations.